Bruno P Mmbando

researcher

Bruno P Mmbando is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0001-7232-8708

P69educated atUniversity of CopenhagenQ186285
P108employerNational Institute for Medical ResearchQ30280978
P735given nameBrunoQ1874605
BrunoQ1874605
P106occupationresearcherQ1650915

Reverse relations

author (P50)
Q34060866A progressive declining in the burden of malaria in north-eastern Tanzania
Q59135916A ten year review of the sickle cell program in Muhimbili National Hospital, Tanzania
Q35133809Accuracy of malaria rapid diagnostic tests in community studies and their impact on treatment of malaria in an area with declining malaria burden in north-eastern Tanzania
Q33537503Acquisition of antibodies to merozoite surface protein 3 among residents of Korogwe, north eastern Tanzania
Q37211878Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial
Q90086292Anemia among Schoolchildren with Malaria and Soil-Transmitted Helminth Coinfections after Repeated Rounds of Mass Drug Administration in Muheza District, Tanzania
Q35681701Bloodstream bacterial infection among outpatient children with acute febrile illness in north-eastern Tanzania
Q89946462Cerebral Infarcts and Vasculopathy in Tanzanian Children With Sickle Cell Anemia
Q24815535Cytophilic antibodies to Plasmodium falciparum glutamate rich protein are associated with malaria protection in an area of holoendemic transmission
Q37363924Declining burden of malaria over two decades in a rural community of Muheza district, north-eastern Tanzania
Q38648354Deployment and use of mobile phone technology for real-time reporting of fever cases and malaria treatment failure in areas of declining malaria transmission in Muheza district north-eastern Tanzania
Q90250485Detection of Plasmodium falciparum by Light Microscopy, Loop-Mediated Isothermal Amplification, and Polymerase Chain Reaction on Day 3 after Initiation of Artemether-Lumefantrine Treatment for Uncomplicated Malaria in Bagamoyo District, Tanzania: A
Q34157083Determinants of delay in care seeking among children under five with fever in Dodoma region, central Tanzania: a cross-sectional study
Q36710616Differences in human antibody reactivity to Plasmodium falciparum variant surface antigens are dependent on age and malaria transmission intensity in northeastern Tanzania
Q35006691Early infant diagnosis of HIV in three regions in Tanzania; successes and challenges
Q33830353Effect of physicochemical parameters on Anopheles and Culex mosquito larvae abundance in different breeding sites in a rural setting of Muheza, Tanzania
Q37289589Epidemiology of malaria in an area prepared for clinical trials in Korogwe, north-eastern Tanzania
Q58828049Establishing and implementing Demographic Surveillance System as a tool for monitoring health interventions in Korogwe District, north-eastern Tanzania
Q39703200Establishing and implementing Demographic Surveillance System as a tool for monitoring health interventions in Korogwe District, northastern Tanzania
Q100729330F cell numbers are associated with an X-linked genetic polymorphism and correlate with haematological parameters in patients with sickle cell disease
Q38606802Fetal Hemoglobin is Associated with Peripheral Oxygen Saturation in Sickle Cell Disease in Tanzania
Q41938717Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene.
Q35576807Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancer
Q36532564Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania
Q34456358Genome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania
Q35828475Haemoglobin and haematocrit: is the threefold conversion valid for assessing anaemia in malaria-endemic settings?
Q36336828Haplotypes of the endothelial protein C receptor (EPCR) gene are not associated with severe malaria in Tanzania
Q33820356Health and social support services to HIV/AIDS infected individuals in Tanzania: employees and employers perceptions
Q125724586High Prevalence of Glaucoma among Patients in an Onchocerciasis Endemic Area (Mahenge, Tanzania)
Q41690766High prevalence of individuals with low concentration of fetal hemoglobin in F-cells in sickle cell anemia in Tanzania
Q35833840IgG antibodies to endothelial protein C receptor-binding cysteine-rich interdomain region domains of Plasmodium falciparum erythrocyte membrane protein 1 are acquired early in life in individuals exposed to malaria
Q39170588Impact of insecticide treated mosquito nets and low dose monthly diethylcarbamazine on lymphatic filariasis infection between 1999 and 2004 in two endemic communities of north-eastern Tanzania.
Q34601747Levels of plasma immunoglobulin G with specificity against the cysteine-rich interdomain regions of a semiconserved Plasmodium falciparum erythrocyte membrane protein 1, VAR4, predict protection against malarial anemia and febrile episodes
Q43938323Lost to follow up and clinical outcomes of HIV adult patients on antiretroviral therapy in care and treatment centres in Tanga City, north-eastern Tanzania
Q24800714Malaria morbidity and immunity among residents of villages with different Plasmodium falciparum transmission intensity in North-Eastern Tanzania
Q35597882Negative Epistasis between Sickle and Foetal Haemoglobin Suggests a Reduction in Protection against Malaria
Q92404432Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania
Q59294080OCCURRENCE OF DAY 3 SUBMICROSCOPICPLASMODIUM FALCIPARUMPARASITAEMIA BEFORE AND AFTER IMPLEMENTATION OF ARTEMETHER-LUMEFANTRINE TREATMENT POLICY IN TANZANIA
Q64282544Onchocerciasis-associated epilepsy: another piece in the puzzle from the Mahenge mountains, southern Tanzania
Q30883674Parasite threshold associated with clinical malaria in areas of different transmission intensities in north eastern Tanzania
Q55034809Pattern of all-causes and cause-specific mortality in an area with progressively declining malaria burden in Korogwe district, north-eastern Tanzania.
Q37129311Performance of rapid diagnostic test, blood-film microscopy and PCR for the diagnosis of malaria infection among febrile children from Korogwe District, Tanzania
Q43942766Plasma cytokine levels in Tanzanian HIV-1-infected adults and the effect of antiretroviral treatment.
Q34853037Plasmodium falciparum expressing domain cassette 5 type PfEMP1 (DC5-PfEMP1) bind PECAM1.
Q37262379Plasmodium falciparum mutant haplotype infection during pregnancy associated with reduced birthweight, Tanzania
Q57321339Possible Risk Factors for Severe Anemia in Hospitalized Sickle Cell Patients at Muhimbili National Hospital, Tanzania: Protocol for a Cross-Sectional Study
Q57321340Possible Risk Factors for Severe Anemia in Hospitalized Sickle Cell Patients at Muhimbili National Hospital, Tanzania: Protocol for a Cross-Sectional Study (Preprint)
Q53701676Possible Risk Factors for Severe Anemia in Hospitalized Sickle Cell Patients at Muhimbili National Hospital, Tanzania: Protocol for a Cross-Sectional Study.
Q90136889Prevalence and Factors Associated with Human Parvovirus B19 Infection in Sickle Cell Patients Hospitalized in Tanzania
Q41532840Prevalence and prognostic implications of anaemia and iron deficiency in Tanzanian patients with heart failure
Q64106192Prevalence of and Risk Factors Associated with Polymerase Chain Reaction-Determined Positivity on Day 3 after Initiation of Artemether-Lumefantrine Treatment for Uncomplicated Malaria in Bagamoyo District, Tanzania
Q35576130Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy
Q33585751Profile of C-reactive protein, white cells and neutrophil populations in febrile children from rural north-eastern Tanzania
Q34035143Prospective study on severe malaria among in-patients at Bombo regional hospital, Tanga, north-eastern Tanzania
Q39369618Rates and risk factors of hypertension in adolescents and adults with sickle cell anaemia in Tanzania: 10 years' experience
Q36166540Rationale and design of mDOT-HuA study: a randomized trial to assess the effect of mobile-directly observed therapy on adherence to hydroxyurea in adults with sickle cell anemia in Tanzania
Q43944578Reduced risk of uncomplicated malaria episodes in children with alpha+-thalassemia in northeastern Tanzania
Q40043244Relationships between sickle cell trait, malaria, and educational outcomes in Tanzania
Q36991071Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania
Q35068274Spatial variation and socio-economic determinants of Plasmodium falciparum infection in northeastern Tanzania
Q35198729Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children
Q40075427Sustained High Cure Rate of Artemether-Lumefantrine against Uncomplicated Plasmodium falciparum Malaria after 8 Years of Its Wide-Scale Use in Bagamoyo District, Tanzania
Q55541304Trends of Plasmodium falciparum prevalence in two communities of Muheza district North-eastern Tanzania: correlation between parasite prevalence, malaria interventions and rainfall in the context of re-emergence of malaria after two decades of progr
Q36453649Using community-owned resource persons to provide early diagnosis and treatment and estimate malaria burden at community level in north-eastern Tanzania

Search more.